(Q46685680)

24 December 2017

title

Berbamine inhibited the growth of prostate cancer cells in vivo and in vitro via triggering intrinsic pathway of apoptosis (English)

1 reference

24 December 2017

author name string

Y Zhao

1

1 reference

24 December 2017

J J Lv

2

1 reference

24 December 2017

J Chen

3

1 reference

24 December 2017

X B Jin

4

1 reference

24 December 2017

M W Wang

5

1 reference

24 December 2017

Z H Su

6

1 reference

24 December 2017

L Y Wang

7

1 reference

24 December 2017

H Y Zhang

8

1 reference

24 December 2017

publication date

19 July 2016

1 reference

24 December 2017

Prostate Cancer and Prostatic Diseases

published in

1 reference

24 December 2017

volume

19

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

358-366

1 reference

24 December 2017

Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Suppression of human lung cancer cell growth and migration by berbamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

21 January 2018

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

New therapies for castration-resistant prostate cancer: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Systems biology of death receptor networks: live and let die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Mitochondrial swelling and incipient outer membrane rupture in preapoptotic and apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Caspase-dependent and -independent death pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

External Validation of a Prognostic Model Predicting Overall Survival in Metastatic Castrate-resistant Prostate Cancer Patients Treated with Abiraterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Effect of berbamine on blood and bone-marrow stem cells of cyclophosphamide-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Electrospray ionization mass spectrometry probing of binding affinity of berbamine, a flexible cyclic alkaloid from traditional Chinese medicine, with G-quadruplex DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Effect and mechanism of poly (ADP-ribose) polymerase-1 in aldosterone-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2016.29

Mitochondria and apoptosis: emerging concepts.

31 March 2020

1 reference

12 December 2020

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs

1 reference

12 December 2020

In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment

1 reference

12 December 2020

An update on PARP inhibitors for the treatment of cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/PCAN.2016.29

1 reference

24 December 2017

1 reference

24 December 2017